Advances in Immuno-Oncology for CNS Tumors

This track invites abstracts on the latest developments in immuno-oncology for central nervous system (CNS) tumors. Researchers should focus on novel immunotherapeutic approaches, including immune checkpoint inhibitors, CAR-T cell therapy, and vaccines targeting CNS malignancies. Submissions that address the unique challenges of treating brain tumors, such as the blood-brain barrier and tumor microenvironment, are highly encouraged. Attendees will learn about the cutting-edge research that is driving new treatment options for CNS tumors, offering hope for improved outcomes in this challenging field.

    Related Conference of Advances in Immuno-Oncology for CNS Tumors

    August 27-28, 2026

    30th European Nephrology Conference

    Berlin, Germany
    September 21-22, 2026

    18th World Nephrology Summit

    Paris, France
    November 10-11, 2026

    13th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    November 16-17, 2026

    12th World Kidney Congress

    Tokyo, Japan
    March 29-30, 2027

    23rd World Nephrology Conference

    Amsterdam, Netherlands
    March 30-31, 2027

    18th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE

    Advances in Immuno-Oncology for CNS Tumors Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in